KV Bankruptcy May Hurt FDA's Unapproved Drug Initiative - Law36...

KV Bankruptcy May Hurt FDA's Unapproved Drug Initiative
Law360 (subscription)
In its Chapter 11 bankruptcy filing Saturday, K-V blamed its financial troubles on the FDA for undermining its exclusivity on Makena, a drug meant to prevent preterm births. Makena was approved in February 2011, as part of the FDA's efforts to... To ...